Avricore Health (TSE:AVCR) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Avricore Health Inc. has reported significant mid-year financial growth for 2024, with a 84% increase in revenue and a net profit of $222,559. The company attributes its success to strong partnerships, a dedicated team, and a mission focused on improving access to healthcare. With consecutive profitable quarters and a solid increase in working capital, Avricore is showing potential for further growth in the healthcare sector.
For further insights into TSE:AVCR stock, check out TipRanks’ Stock Analysis page.